Medication safety

Pharmacists have been aware for a long time that there are specific risks related to medicines in children and young people, above those for the rest of the population. This is partly due to the need for bespoke dosing, the massive variation in our population from premature infants to adult sized teenagers, the use of off-label and unlicensed medicines, liquid formulations of various strengths, and more. In particular, 10x overdoses are something we are conscious about, with the potential to cause significant harm, and the recent HSIB report into weight based dosing put this in sharp focus. The clinical practice guideline is a first step towards tackling this, providing agreed standards for how medicines should be considered on ward rounds for paediatric inpatients, as well as after discharge. This work has been a joint venture between the Royal College of Paediatrics and Child Health (RCPCH) and the Neonatal & Paediatric Pharmacy Group (NPPG) through their Joint Medicines Committee

Access the guidance here